Manufacturer profile
Chemical House
Manufacturer snapshot
Overview of registrations for this manufacturer
20
Total Registrations
20
Distinct Products
3/8/2023
Latest Registration
8/3/2021
Earliest
Risk class distribution
Risk C7
Risk D6
Risk B5
Risk A1
Registrations (20)
Click a registration number to view details
Lyphochek whole
Blood
Immunosuppressant
Controls
(Multiple whole Blood
Immunosuppressant
Therapeutic Drug
Monitoring IVD
Control)3/8/2023
Registration: MDIR-0004910
Risk Class: C
Expires: 3/7/2028
BIOPLEX 2200 MMRV
IgG
(Measles, Mumps
Rubella, Varicella
zoster virus 1 GG
antibody IVD Kit)3/8/2023
Registration: MDIR-0004911
Expires: 3/7/2028
Geenius HIV
(EIA Microplate
Format)
[72460, 72329]1/11/2023
Registration: MDIR-0004546
Risk Class: D
Expires: 1/10/2028
Genscreen Ultra HIV
Ag-Ab assay
(EIA Microplate
Format)
[72386, 72388]1/11/2023
Registration: MDIR-0004545
Risk Class: D
Expires: 1/10/2028
Monolisa HBs Ag Ultra
(Catalogue # 72346,
72348,72408).
(EIA Microplate
Formate-HBV antigen
antibody detection)1/11/2023
Registration: MDIR-0004544
Risk Class: D
Expires: 1/10/2028
Geenius HCV
Supplement Assay &
Control Kit
(Immunochromat
ographic test)
[92501, 92502]1/11/2023
Registration: MDIR-0004547
Risk Class: D
Expires: 1/10/2028
Liquichek Torch Plus
Controls
(Infectious Disease
Controls)
[Positive (3x3mL) -
227;
Positive MiniPak
(1x3mL) - 227x;
Negative (3x3mL) -
228;
Negative MiniPak
(1x3mL) - 228x]1/11/2023
Registration: MDIR-0004543
Risk Class: C
Expires: 1/10/2028
BIO-RAD Virotrol I
(Control)1/11/2023
Registration: MDIR-0004542
Risk Class: D
Expires: 1/10/2028
LIQUICHEK
(Multiple Whole Blood
Immunosuppressant
Therapeutic Drug
Monitoring IVD
Control)8/16/2022
Registration: MDIR-0003629
Risk Class: C
Expires: 8/15/2027
Liquichek Tumor
Marker Control8/16/2022
Registration: MDIR-0003631
Risk Class: C
Expires: 8/15/2027
LYPHOCHEK
Immunoassay Plus
Controls.
(Quality Control)8/16/2022
Registration: MDIR-0003628
Risk Class: C
Expires: 8/15/2027
Lyphochek Tumor
Marker Plus Controls8/16/2022
Registration: MDIR-0003630
Risk Class: C
Expires: 8/15/2027
BIO-RAD Syphilis
Total Ab (Kit)
[72530-96 tests
72531-480 tests]7/22/2022
Registration: MDIR-0003425
Risk Class: D
Expires: 7/21/2027
PLATELLA DENGUE
NS1 Ag
(Dengue Virus NSI
Antigen IVD Kit)
[72830 (96 tests)]7/22/2022
Registration: MDIR-0003424
Risk Class: C
Expires: 7/21/2027
D-10 Dual Program
Reorder Pack
[2200201 ]1/17/2022
Registration: MDIR-0003157
Risk Class: B
Expires: 1/16/2027
Variant II Hemoglobin
Testing System
[HbA1C Quantification]1/17/2022
Registration: MDIR-0003161
Risk Class: B
Expires: 1/16/2027
D-100 Hemoglobin
Testing System
[HbA1C Quantification]1/17/2022
Registration: MDIR-0003160
Risk Class: B
Expires: 1/16/2027
Variant II Hb Testing
System
Diabetes Testing
Reagent1/17/2022
Registration: MDIR-0003159
Risk Class: B
Expires: 1/16/2027
D-100 HbA1c
Reagents
Diabetes Testing
Reagent1/17/2022
Registration: MDIR-0003158
Risk Class: B
Expires: 1/16/2027
Evolis Twin Plus
Microplate Analyzer
[93501]8/3/2021
Registration: MDIE-0000298
Risk Class: A
Expires: 8/2/2026
About this profile
Access the DRAP portfolio for Chemical House via Pure Global AI. This manufacturer holds 20 registrations across 20 distinct products, with registrations ranging from 8/3/2021 to 3/8/2023 and spanning 4 risk classes.
This mirrors the Brazil holder experience with a concise snapshot and direct links to each DRAP registration.
Free DatabasePowered by Pure Global AIPakistan DRAP